AstraZeneca PLC/ GB0009895292 /
| 2024-04-26 9:01:07 AM | Chg. +152.25 | Volume | Bid3:32:32 PM | Ask5:09:54 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1,646.50SEK | +10.19% | 75 Turnover: 123,487.50 |
-Bid Size: - | -Ask Size: - | 2505.67 bill.SEK | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.84 USD | 81.13% |
| EPS Diluted: | - USD | 80.57% |
| Revenues per Share: | 29.55 USD | 3.28% |
| Book Value per Share: | 25.25 USD | 5.68% |
| Cash Flow per Share: | 6.67 USD | 5.46% |
| Dividend per Share: | 2.90 USD | 0.00% |
| Total | in mill. | |
| Revenues: | 45,811.00 USD | 3.29% |
| Net Income: | 5,955.00 USD | 84.48% |
| Operating Cash Flow: | 10,345.00 USD | - |
| Cash and Cash Equivalents: | 5,840.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 39.08 | 35.16 |
| P/S Ratio: | 5.08 | 4.57 |
| P/BV ratio: | 5.94 | 5.35 |
| P/CF Ratio: | 22.48 | 20.23 |
| PEG: | 0.48 | 0.43 |
| Earnings Yield: | 2.56% | 2.84% |
| Dividend Yield: | 1.93% | 2.15% |
| Market Capitalization | ||
| Market Capitalization: | 2505.67 bill. SEK | 2110.49 bill. SEK |
| Free Float Market Cap.: | 1844.17 bill. SEK | - SEK |
| Market Cap. / Employee: | 27.89 mill. SEK | 23.48 mill. SEK |
| Shares Outstanding: | 1.55 bill. | |
Profitability
| Gross Profit Margin: | 81.95% |
| EBIT Margin: | 17.88% |
| Net Profit Margin: | 13.00% |
| Return on Equity: | 15.21% |
| Return on Assets: | 5.89% |
Financial Strength
| Liquidity I / Cash Ratio: | 19.12% |
| Liquidity II / Quick Ratio: | 58.82% |
| Liquidity III / Current Ratio: | 82.03% |
| Debt / Equity Ratio: | 158.33% |
| Dynam. Debt / Equity Ratio: | 599.09% |
Efficiency
| Employees: | 89,900 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 509,577.31 USD |
| Net Income / Employee: | 66,240.27 USD |
| Total Assets / Employee: | 1,124,794.22 USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | USD |
